Recessive Clinical Trials in Cincinnati, Ohio
3 recruitingCincinnati, Ohio
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosaDystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis Bullosa+1 more
Krystal Biotech, Inc.16 enrolled5 locationsNCT07016750
Recruiting
Phase 3
A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)
Autosomal Recessive Polycystic Kidney (ARPKD)
Otsuka Pharmaceutical Development & Commercialization, Inc.20 enrolled23 locationsNCT04782258
Recruiting
ARPKD Database Study
Autosomal Recessive Polycystic Kidney DiseaseNephronophthisisCongenital Hepatic Fibrosis+7 more
Children's Hospital of Philadelphia200 enrolled6 locationsNCT01401998